IPO Listed — 17 Aug 2026
Listing Price: ₹980 (+21.44% vs ₹807)
Molbio Diagnostics IPO Review
Molbio Diagnostics IPO has been reviewed by 7 analysts, and the overall consensus is Strong Apply — carrying a score of 89. Out of the 7 analysts who have covered this IPO, 5 recommend subscribing while 2 advise caution or avoidance — reflecting a mixed view from the analyst community.
The issue is priced in the band of ₹768-807 per share , with a minimum application size of 18 shares (minimum investment of approximately ₹14,526 at the upper band) . Subscription ran from 10 Aug 2026 to 12 Aug 2026. As of now, the grey market premium (GMP) for Molbio Diagnostics IPO is quoting at ₹120 (14.87%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.
General Review
Listing Gains
Short Term Strategy
Long Term Strategy
Disclaimer: This review is an AI summary derived from the reviews of all analysts.
Table of Contents
Recommend Subscribe
Based on 7 analyst reviews
Higher consensus indicates broader analyst agreement.
Analyst Review
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Molbio Diagnostics IPO?
Based on analyst coverage tracked on this page, the overall verdict for Molbio Diagnostics IPO is Strong Apply. Out of 7 analysts who have reviewed this IPO, 5 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.
What does the score of 89 mean for Molbio Diagnostics IPO?
The score of 89 is an aggregate of all analyst ratings tracked for Molbio Diagnostics IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.
What was the actual listing price of Molbio Diagnostics IPO?
Molbio Diagnostics IPO listed on August 17, 2026 at ₹980 , against the issue price of ₹807 — a gain of +21.44% (₹173 per share). View the full GMP history page for day-wise pre-listing trends.
What is the price band and lot size of Molbio Diagnostics IPO?
Molbio Diagnostics IPO was priced at ₹768-807 per share. The minimum lot size is 18 shares, making the minimum investment approximately ₹14,526 at the upper end of the price band. Subscription ran from 10 Aug 2026 to 12 Aug 2026.
Explore Molbio Diagnostics IPO Further
Track every stage of this IPO:
